These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 11796827
1. EGFR and ErbB2 differentially regulate Raf-1 translocation and activation. Zhang L, Bewick M, Lafrenie RM. Lab Invest; 2002 Jan; 82(1):71-8. PubMed ID: 11796827 [Abstract] [Full Text] [Related]
2. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Wang Z, Zhang L, Yeung TK, Chen X. Mol Biol Cell; 1999 May; 10(5):1621-36. PubMed ID: 10233167 [Abstract] [Full Text] [Related]
3. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH. EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020 [Abstract] [Full Text] [Related]
4. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R. Cytometry; 2001 Aug 01; 44(4):338-48. PubMed ID: 11500850 [Abstract] [Full Text] [Related]
5. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites. Sasaoka T, Langlois WJ, Bai F, Rose DW, Leitner JW, Decker SJ, Saltiel A, Gill GN, Kobayashi M, Draznin B, Olefsky JM. J Biol Chem; 1996 Apr 05; 271(14):8338-44. PubMed ID: 8626530 [Abstract] [Full Text] [Related]
6. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Saito T, Okada S, Ohshima K, Yamada E, Sato M, Uehara Y, Shimizu H, Pessin JE, Mori M. Endocrinology; 2004 Sep 05; 145(9):4232-43. PubMed ID: 15192046 [Abstract] [Full Text] [Related]
7. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. Deb TB, Su L, Wong L, Bonvini E, Wells A, David M, Johnson GR. J Biol Chem; 2001 May 04; 276(18):15554-60. PubMed ID: 11279155 [Abstract] [Full Text] [Related]
8. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH. Meijer IM, van Rotterdam W, van Zoelen EJ, van Leeuwen JE. Cell Signal; 2012 Nov 04; 24(11):1981-8. PubMed ID: 22800866 [Abstract] [Full Text] [Related]
9. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane. Offterdinger M, Bastiaens PI. Traffic; 2008 Jan 04; 9(1):147-55. PubMed ID: 17956594 [Abstract] [Full Text] [Related]
13. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion. Xian W, Rosenberg MP, DiGiovanni J. Oncogene; 1997 Mar 27; 14(12):1435-44. PubMed ID: 9136987 [Abstract] [Full Text] [Related]
15. The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane. Haslekås C, Breen K, Pedersen KW, Johannessen LE, Stang E, Madshus IH. Mol Biol Cell; 2005 Dec 27; 16(12):5832-42. PubMed ID: 16207817 [Abstract] [Full Text] [Related]